|
× |
 |
Effects of Parental Severe Mental Disorders on All-Cause and Suicide Mortalities in Adolescents and Young Adults With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Potential Mental Health Needs of US Adult Residents Under Different Provisions of the Affordable Care Act PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Response to Past Depression Treatments Is Not Accurately Recalled: Comparison of Structured Recall and Patient Health Questionnaire Scores in Medical Records PDF |
$40.00 |
|
$40.00 |
|
× |
|
Relationship Between Exposure to Emotional Neglect and the Inflammatory Biomarkers Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, and Platelet-to-Lymphocyte Ratios in Patients With First-Episode Psychosis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Relevance of Family History of Suicide in the Long-Term Outcome of Bipolar Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Galantamine-Memantine Combination for Cognitive Impairments Due to Electroconvulsive Therapy, Traumatic Brain Injury, and Neurologic and Psychiatric Disorders: Kynurenic Acid and Mismatch Negativity Target Engagement PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prediction of Remission as a Combination of Symptomatic and Functional Remission and Adequate Subjective Well-Being in 2960 Patients With Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Coprescribed Benzodiazepines in Older Adults Receiving Antidepressants for Anxiety and Depressive Disorders: Association With Treatment Outcomes PDF |
$40.00 |
|
$40.00 |
|
× |
|
Age at the Time of Exposure to Trauma Modulates the Psychopathological Profile in Patients With Early Psychosis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals: A 3-Year Naturalistic Follow-Up Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Open-Label Study of Levetiracetam for the Treatment of Social Anxiety Disorder PDF |
$40.00 |
|
$40.00 |
|
|
